CAS: 1331782-27-4

4-[[4-[[4-[(3R)-Oxolan-3-Yl]Oxy-1,2-Benzoxazol-3-Yl]Oxymethyl]Piperidin-1-Yl]Methyl]Oxan-4-Ol

PF-04995274

PF-04995274: potent, selective partial 5-HT4R agonist; EC50 0.26-0.47 nM; brain penetrant; may treat Alzheimer's cognitive issues.

PF-04995274 is a potent, selective 5-HT4 receptor agonist. It has been shown to be safe and effective in the treatment of cancer and diabetes, with few side effects. PF-04995274 is currently in clinical development for use as an antidepressant and anxiolytic, with some success. This drug has the potential to be used for the treatment of depression, anxiety, and other mood disorders. It binds to the 5-HT4 receptor on the cell membrane, leading to increased serotonin release in certain areas of the brain. Moreover, this drug possesses serotonergic activity and may also act as a tautomerase inhibitor or pyrimidine antagonist. The synthesis of PF-04995274 involves bioanalysis followed by chemical synthesis of various intermediates. The synthesized intermediate is then reacted with sodium azide to produce PF-04995274.